Inma Fuentes

Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients

J. A. Arranz, P. Suñé, E. Román, 2016, Therapeutic advances in gastroenterology.

Consent in clinical trials: what do patients know?

P. Suñé, X. Vidal, Inma Fuentes, 2010, Contemporary clinical trials.

The DEC-net European register of paediatric drug therapy trials: contents and context

C. Pandolfini, M. Bonati, I. Choonara, 2008, European Journal of Clinical Pharmacology.

Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.

J. Sánchez-Delgado, P. Ginès, E. Román, 2013, Journal of hepatology.

Safety of Ornithine Phenylacetate in Cirrhotic Decompensated Patients: An Open-label, Dose-escalating, Single-cohort Study

J. A. Arranz, P. Suñé, J. Córdoba, 2013, Journal of clinical gastroenterology.